CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models CXCR4 Inhibition Has Anti-Tumor and Anti-Metastatic Effects in Prostate Cancer Models
Saved in:
Published in | The Prostate Vol. 75; no. 12; pp. 1227 - 1246 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.07.2015
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0270-4137 |
---|---|
DOI: | 10.1002/pros.23007 |